Truvestments Capital »

Atrium Therapeutics shares owned by Truvestments Capital

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Truvestments Capital from 13F filings

Historical chart of Truvestments Capital investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Truvestments Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Truvestments Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $13 1 13.00

More positions owned by Truvestments Capital

NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Apple (AAPL)
Corning Incorporated (GLW)
Caterpillar (CAT)
Celestica (CLS)
Nextera Energy (NEE)
Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
Qualcomm (QCOM)
Kinder Morgan (KMI)
Ryder System (R)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Truvestments Capital

Top funds holding Atrium Therapeutics

BlackRock
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Weiss Asset Management LP[1
Cantor Fitzgerald, L. P.
Balyasny Asset Management
Squarepoint Ops
Fort Hoosac Management

View all funds holding Atrium Therapeutics